supplements with semaglutide FDA Approves Game-Changing Weight Loss Drug Compounded Semaglutide (GLP-1) - 4th

Clinical trials have shown impressive results

Key Points Genetics probably plays a part in GLP-1 response, but it is not the main practical explanation in most cases A new Nature paper found GLP1R and GIPR variants associated with efficacy and side effects, but effect sizes are modest Non-genetic factors drug choice, dose, duration, sex, diabetes status still explain more variation than genetics Current evidence does not justify routine genetic testing before prescribing semaglutide or tirzepatide Most apparent non-responders have correctable clinical reasons for poor response If you are wondering why GLP-1 drugs work better for some people , the short answer is this: genetics probably plays a part, but it is not the main practical explanation in most cases

demand, Novo Nordisk said Friday, as Fierce Pharma reported

doi:10.1038/nchembio.235